HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 P.m. Eastern Time

HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, will hold a conference call on Thursday May 9, 2024 at 4:30 p.m. Eastern time

BusinesswireApr 25 20:31

HeartBeam AI Combined With Vectorcardiography Delivers Equivalent Performance To 12-lead ECG

RTTNewsApr 9 22:00

HeartBeam Presents Positive Results on Its Artificial Intelligence Capabilities for Detecting Arrhythmias

New Data Presented at the European Heart Rhythm Association Conference Marks First Scientific Presentation on HeartBeam AI, the Company's Deep Learning Technology Data Shows HeartBeam AI Combined with VCG Greatly

BusinesswireApr 9 20:31

Heartbeam Price Target Maintained With a $8.00/Share by Benchmark

Heartbeam Price Target Maintained With a $8.00/Share by Benchmark

Dow JonesMar 25 23:18

Benchmark Reiterates Speculative Buy on HeartBeam, Maintains $8 Price Target

Benchmark analyst Bill Sutherland reiterates HeartBeam (NASDAQ:BEAT) with a Speculative Buy and maintains $8 price target.

BenzingaMar 25 23:09

HeartBeam Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/25/2024 279.15% Benchmark → $8 Reiterates Speculative Buy → Speculative Buy 11/16/2023 279.15% Benchmar

BenzingaMar 25 23:06